:: home > What's New?

WHAT'S NEW?

October 2009

Buoluoke gets a new look:

September 01 2009

VIDEO

For our audience who have been inquiring about CanadaRNA's conference material, we hope you enjoy this link:

Berg & Kwok at AEHF 2009 Dallas.mov - 125 megs

Download Quicktime

"This is a CRNA sponsored talk presented by David Berg and Martin Kwok at the AEHF 2009 conference in Dallas. Berg discussed the relationship between chronic illnesses and hypercoagulation/fibrinolysis, and Kwok talked about the latest research on lumbrokinase"

---------------------------------------------------------------------------------------------------

Beware Of Boluoke® Imitation Products!

Boluoke® And Hypercoagulation Video Available For Viewing/Download

First Cordyceps sinensis (Super CS-4) in the world with high cordycepin yield!!

........................................................................................................................................

Beware Of Boluoke® Imitation Products!

Don’t be fooled by imitation products. There is only one Boluoke® (lumbrokinase), the one that is backed by Phase I – III clinical trials in China, the one that is first used in hospitals in China, and covered by the Chinese National Fundamental Health Insurance. Currently some companies are making products with 250mg or 230mg of lumbrokinase per capsule and trying to quote Boluoke®’s credential as their own. Boluoke®’s capsules are of 200mg in size, and contain 20mg of lumbrokinase inside each capsule.

In addition, Boluoke®’s enzymatic strength is standardized against urokinase and t-PA. The imitation products are likely just earthworm protein extract containing little pure lumbrokinase or lumbrokinase of low enzymatic strength. Some products may even claim to have lumbrokinase mixed with proprietary herbal formula, and the ingredients of which they do not disclose. Would you trust your patients’ health to products like these? So make sure your patients are on Boluoke®, the one and only that’s backed by full research and extensive clinical data! (Click here to see the comparison chart between Boluoke and other enzymes)

..................................................................................................................................

Boluoke® And Hypercoagulation Video Available For Viewing/Download

	> Short video on hypercoagulation & Boluoke®		>Short video on hypercoagulation & Boluoke®
	>56.6K - 2-3 MB		> ISDN & DSL - 4-6 MB

Boluoke® has been featured on American Medical Review, a non-commercial educational program dedicated to the investigation of innovative science and medicine. This program is hosted by the renowned “60 Minutes” anchor Morley Safer**, and focuses on the relationship between hypercoagulation and chronic illnesses in plain English.

**Note: Mr. Morley Safer’s image cannot be broadcasted over the Internet. However, the full version of the video with Mr. Safer as the host is available upon request to all active accounts of Canada RNA Biochemical Inc. Others who would like a DVD version of the video may also purchase the video for a nominal fee.

.........................................................................................................................................

First Cordyceps sinensis (Super CS-4) in the world with high cordycepin yield!!!

Canada RNA Biochemical Inc. (CRNA) has done it! We have succeeded in hybridizing a Cordyceps sinensis strain that is capable of producing high yields of both adenosine and cordycepin (3’-deoxyadenosine), and it is named Super CS-4 strain.

Up to now, significant yield of cordycepin can only be obtained from Cordyceps militaris not Cordyceps sinensis, and significant adenosine only from Cordyceps sinensis not Cordyceps militaris. We have achieved high yields of both in Super CS-4 strain Cordyceps sinensis!
What is cordycepin? It is a nucleoside analog (3’-deoxyadenosine), and mainly stops RNA synthesis in cells. It has been shown to be anti-viral (e.g. flu, herpes, HIV, etc.), anti-fungal (e.g. candida), anti-bacterial, anti-tumor, and to also enhance the killing effects of radiation on tumor cells. The National Cancer Institute in US is currently doing a Phase I trial on cordycepin as a potential treatment for leukemia.

Still need more medicinal mushroom raw material for immune support? Please go to our raw material page for the complete list

...................................................................................................................................

The statements above have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.